Letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamide. - Freyer CW; Carulli A; Gier S; Ganetsky A; Timlin C; Schuster M; Babushok D; Frey NV; Gill SI; Hexner EO; Luger SM; Mangan JK; et al. (Leukemia & lymphoma, 2022)